Highlights
-
- This company is a health and wellness company offering sleep aid products through its Dream Water brand, and pain relief products through its LivRelief brand. Currently, 60% of sales come from the U.S., and the Middle East, and 40% from Canada.
- This company’s products are available in over 30k+ stores including established retail/pharmacy chains such as Walmart (NYSE: WMT), Kroger (NYSE: KR), 7-Eleven, Sobeys (TSX: EMP), Rexall (NYSE: MCK), London Drugs, Shoppers Drug Mart (TSX: L), and Amazon Canada (NASDAQ: AMZN).
- In May 2023, this company granted global cannabis company Canopy Growth (TSX: WEED; MCAP: $1.7B) an exclusive licence to manufacture, and sell, cannabis-infused LivRelief topicals in Canada. This company will start receiving licensing fees from Canopy in the coming months.
- In FY2023 (nine months ended March 2023), revenue grew 4% YoY to $6.5M. Gross margins improved as well, and EBITDA turned positive, from -$2.3M in FY2022 (9M), to $9k in FY2023 (9M).
-
-
-
- This report is currently available to premium subscribers – Free subscribers will gain access on Sep 20th, 2022 Join as a FREE member and get our research report delivered straight to your inbox, with a seven-day delay
-
-
Visit Delivra Health Brands Inc. page for more research, discussion boards and to like, and share.
Are you enjoying the highlights?
Discover the company's fair value estimate from our certified analysts, identify potential risks, and explore exciting upcoming catalysts in our detailed report.
